SHARON HILL: Open Payments
NPI 1578286845 · COMMACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 66 payments from 10 companies in 2025. Trend: 2023 $322 · 2024 $2,279 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $702 |
| Otsuka America Pharmaceutical, Inc. | 13 | $231 |
| ABBVIE INC. | 8 | $185 |
| Alkermes, Inc. | 3 | $153 |
| Corium, LLC | 6 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| Lundbeck LLC | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: FANAPT, HETLIOZ, REXULTI, VRAYLAR, Azstarys, LYBALVI, CAPLYTA, Auvelity.
Industry payments across NY — which companies pay providers there.
